Maria Morozova

The efficacy and safety of levilimab in severely ill COVID-19 patients not requiring mechanical ventilation: results of a multicenter randomized double-blind placebo-controlled phase III CORONA clinical study

N. V. Lomakin, G. Musaev, Elena S. Pasechnik et al. · Inflammation Research · 2021 · 53 citations · Full text

Efficacy and Safety of Netakimab, A Novel Anti-IL-17 Monoclonal Antibody, in Patients with Moderate to Severe Plaque Psoriasis. Results of A 54-Week Randomized Double-Blind Placebo-Controlled PLANETA Clinical Trial

L. Puig, Maria Morozova, Nikita A. Zolkin et al. · Dermatology and Therapy · 2021 · 36 citations · Full text

Efficacy and safety of netakimab in patients with psoriatic arthritis: results of the phase III PATERA clinical study

Mazurov Vi, I. Z. Gaydukova, A. Eremeeva et al. · Rheumatology Science and Practice · 2020 · 20 citations · Full text

Rheumatoid Disorder, Rheumatology, Anti-inflammatory +14

Effectiveness and safety of BCD180, anti-TRBV9<sup>+</sup> T-lymphocytes monoclonal antibody in patients with active radiographic axial spondyloarthritis: 36-week results of double-blind randomized placebo-controlled phase II clinical study ELEFTA

Mazurov Vi, I. Z. Gaydukova, S. Lapshina et al. · Rheumatology Science and Practice · 2024 · 12 citations · Full text

Monotonic non-linear transformations as a tool to investigate age-related effects on brain white matter integrity: A Box–Cox investigation

Maria Morozova, Karl Koschutnig, Elise Klein et al. · NeuroImage · 2015 · 10 citations

Box–cox Investigation, Neurodegenerative Diseases, Alzheimer's Disease +12